According to the latest report by IMARC Group, titled “Human Microbiome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global human microbiome market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 18% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.
Informed covered in the report:
- Historical market data from 2016-2021
- CAGR of the market during the forecast period 2022-2027
- Detailed information on factors that will drive market growth during the next five years
- Precise estimation of the Keyword market size and its contribution to the parent market
- Upcoming market trends and changes in consumer behavior
- A thorough analysis of the market’s competitive landscape and detailed information on key players
- Comprehensive details of factors that will challenge the growth of smart meters market key players
Note: We are updating our reports, If you want the latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Industry Overview and Application:
The human microbiome represents the genes present within the microorganisms found in the genetic portrait or metagenome of humans. It comprises numerous microorganisms, such as bacteria, protozoa, fungi, non-living viruses, single-celled organisms, etc., which impact human physiology and promote the enhancement or impairment of immune and metabolic functions. They are found in human tissues and are studied for various medical advancements and analytical techniques. Microbiomes are utilized in prebiotics, probiotics, pharmaceutical drugs, diagnostic and therapeutic systems, etc., for different ailments, including diabetes, obesity, cancer, etc., and disorders such as metabolic, neurological, gastrointestinal, central nervous system, autoimmune, etc.
Download Free Sample of the Report: https://www.imarcgroup.com/human-microbiome-market/requestsample
Market Trends and Drivers:
The growing incidences of infections and chronic lifestyle diseases across the globe owing to microbial dysbiosis are among the key factors driving the human microbiome market. Moreover, the expanding geriatric population, who are more susceptible to such ailments, is further propelling the product demand. In addition to this, the elevating focus on developing human microbiome therapeutics with enhanced efficacy is acting as another growth-inducing factor. Furthermore, the sudden onset of the COVID-19 pandemic is also bolstering the market growth since researchers are extensively studying the lung microbiomes to determine the severity of the infections and to produce appropriate therapeutics and vaccines. Besides this, various advancements in target-specific microbiome-based therapies are anticipated to fuel the human microbiome market over the forecasted period.
Competitive Landscape with Key Players:
- 4D pharma plc
- Atlas Biomed Group Limited
- BIOHM
- BiomX
- Bione
- DayTwo Inc.
- ENTEROME
- Ferring B.V.
- Finch Therapeutics
- Second Genome Inc.
- SynBioBeta LLC
- Synthetic Biologics Inc.
- Vedanta Biosciences Inc.
- Viome Inc.
Key Highlights of the Market Segmentation:
The report has segmented the global human microbiome market on the basis of product, application, disease type and region.
Breakup by Product:
- Probiotics
- Prebiotics
- Diagnostic Tests
- Drugs
- Medical Food
- Others
Breakup by Application:
- Therapeutics
- Diagnostics
Breakup by Disease Type:
- Obesity
- Diabetes
- Autoimmune Disorders
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC List of Figures: https://www.imarcgroup.com/request?type=reportid=4420flag=F
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe Africa: +44-753-713-2163 | Asia: +91-120-433-0800
